HOSPITAL UNIVERSITARIO RUBER
Departamento
University of Toronto
Toronto, CanadáPublicaciones en colaboración con investigadores/as de University of Toronto (8)
2023
-
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors
Molecular Cancer, Vol. 22, Núm. 1
-
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations
The Lancet Oncology, Vol. 24, Núm. 4, pp. e172-e185
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer: Results from the multicohort phase II FINESSE study
Clinical Cancer Research, Vol. 26, Núm. 2, pp. 354-363
2019
-
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study
Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404
2015
-
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
British Journal of Cancer, Vol. 112, Núm. 4, pp. 650-659
2014
2012
-
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery
European Journal of Cancer, Vol. 48, Núm. 4, pp. 475-481